Introduction
Adrenomedullin (AM), calcitonin gene-related peptide (CGRP) and amylin (AMY) are currently considered to belong to the CGRP superfamily (1, 2) . AM, the newest member of this superfamily, was originally isolated from human pheochromocytoma tissue extracts and elicits a potent depressor effect (3) . Plasma AM concentrations are elevated in patients with hypertension (4), but AM is now known to be synthesized in almost all types of cells and tissues in addition to the adrenal medulla (5) . CGRP was first discovered as be members of the CGRP/CT superfamily.
Although calcitonin receptor (CTR) has been cloned and sequenced in 1991, identification of receptors for these peptides except for CT was retarded compared with other biologically active peptide receptors (9) . In 1998, McLatchie revealed the presence of a complex ligand-receptor recognition system for AM and CGRP by identifying 3 receptor-activitymodifying proteins (RAMPs) (10) . Although the calcitonin receptor-like receptor (CRLR), a G-protein coupled receptor (GPCR) with seven membrane-spanning domains, was identified in 1996, the affinity of CRLR was suggested to be inadequate for specific interaction with CGRP (11, 12) . RAMPs clearly regulate the ligand-affinity and specificity of the CRLR; the CGRP-specific receptor is generated by coexpression with RAMP1, while the AM-specific receptor is formed by co-expression with RAMP2 or RAMP3. Furthermore, RAMP1 and RAMP3 have been reported to alter the CTR to be more specific for AMY (13, 14) . To date, these investigations of the receptor specificity of CRLR and CTR have been performed mainly in humans. In this study, therefore, we cloned and determined sequences of porcine RAMPs, and analyzed their properties by co-expressing them with porcine CRLR or CTR in COS-7 cells and porcine aortic vascular smooth muscle cells (PASMC).
Since AM-producing cells are more widely distributed than those of CGRP, the signals of AM and CGRP are deduced to be regulated by the receptors, i.e., by the expression levels of RAMPs. In fact, the expression and plasma levels of AM are elevated by endotoxin and inflammatory cytokines, and the transcription of RAMPs and CRLR genes is also dynamically regulated by substances related to inflammation (15) (16) (17) (18) . Thus, the ligand-receptor specificity of CRLR, CTR and RAMPs in the porcine system is expected to extend our knowledge of the physiological function of the CGRP/CT superfamily.
Methods

Materials
Porcine CGRP was prepared by American Peptide Company (Sunnyvale, USA), and porcine CT was purchased from Peninsula (San Carlos, USA). Human AM was donated by Shionogi & Co. (Osaka, Japan), and human AMY was a product of the Peptide Institute (Osaka, Japan). COS-7 (CRL-1651) and LLC-PK1 (CL-101) cells were obtained from American Type Culture Collection (ATCC). PASMC and porcine aortic endothelial cells (PAEC) were donated by M. Fujimoto (Shionogi & Co.) and Y. Saito (Nara Medical University, Nara, Japan), respectively.
Preparation of Partial CTR and CRLR cDNA by Polymerase Chain Reaction (PCR)
Total RNA (10 µg) obtained from porcine lung and hypothalamus was each reverse-transcribed using Superscript II reverse transcriptase (Invitrogen Life Technologies, Carlsbad, USA) according to the manufacturer's protocol. Partial cDNAs of CTR and CRLR were obtained by PCR. Each reaction contained 0.2 mmol/l of each dNTP, 40 U/ml of KOD polymerase (Toyobo, Osaka, Japan), a 1-fold concentration of the reaction buffer provided with the enzyme, 1/50 of the porcine hypothalamus cDNA (for CTR) or the lung cDNA (for CRLR) prepared as described above, and a pair of each PCR-specific primer (ATGAGGTTCACACTTACACGCT GGTGC and TCACGATGCTGTATTTGCGTCACGT for CTR; ATGGAGAAAAAGTATATCCTGTATTT and TTC CATTTAAGTGTTCGCTTGGATAG for CRLR; 1 µmol/l of each) (9, 19) . The amplification was performed for 35 cycles (each cycle consisted of 15 s at 94 ºC, 15 s at 58 ºC, and 2 min at 72 ºC). The amplified DNA fragments were separated by TAE (40 mmol/l Tris-acetate and 1 mmol/l EDTA)-agarose electrophoresis, recovered from the gel, and subcloned into pBluescript II KS (Stratagene, La Jolla, USA). The DNA sequence was determined by the dideoxynucleotide chain termination method using a 373A DNA sequencer (Applied Biosystems, Foster City, USA).
Preparation of cDNA Libraries from Porcine Lung and Hypothalamus
Total RNA was obtained from porcine lung and hypothalamus by the acid guanidine thiocyanate/phenol/chloroform method. Poly(A) RNA was purified from total RNA using Oligotex-dT30 (Super, Takara Shuzo, Tokyo, Japan). cDNA was synthesized from 3 µg of poly(A) RNA using the Timesaver cDNA synthesis kit (Amersham Pharmacia Biotech, Piscataway, USA), inserted into λZAP II bacteriophage vector (Stratagene), and packaged in vitro using Giga Pack Gold III packaging extract (Stratagene). Approximately 3 10 5 and 10 5 independent clones were obtained from porcine lung and hypothalamus RNA, respectively. Molecular Cloning and Determination of the cDNA Sequences of Porcine CRLR, RAMP1, RAMP2, RAMP3 and CTR Partial cDNAs of porcine CTR and CRLR were obtained as described above. Rat RAMP1, RAMP2 and RAMP3 cDNAs encoding respective open reading frames were isolated as described previously (20) . All cDNAs were radiolabeled by 32 P using a random primer labeling kit (Takara Shuzo). Phages were plated at a density of 2 10 4 pfu per 135 95 mm plate. Duplicated filter lifts were made from each plate and hybridized with the mixture of 32 P-labeled cDNA in a hybridization buffer containing formamide (50% for CRLR and CTR, and 20% for RAMPs), 0.09 mol/l sodium citrate (pH 7.0), 0.9 mol/l NaCl, and 0.5% each of bovine serum albumin (BSA), Ficoll, polyvinylpyrrolidone and sodium dodecyl sulfate (SDS) at 42 ºC. Following hybridiza-tion for 16 h, filters were washed twice with 2 SSC (1 SSC 0.15 mol/l NaCl and 0.015 mol/l sodium citrate) containing 0.1% SDS for 5 min at room temperature and washed twice with 0.2 SSC (for CTR and CRLR) or 0.5 SSC (for RAMPs) containing 0.1% SDS at 65 ºC for 1 h. The filters were exposed to RX-U films (Fuji, Tokyo, Japan). Isolated positive clones were rescued as pBluescript SK using Escherichia coli strain SOLR and helper phage. DNA sequences of these clones were determined by the dideoxynucleotide chain termination method.
Cell Culture
COS-7 cells and PASMC were cultured with Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal bovine serum (FBS; Filtron, Victoria, Australia), supplemented with 100 µg/ml penicillin and 100 U/ml streptomycin in a humidified atmosphere of 95% air-5% CO2 at 37 ºC. PASMC was used at passages 13-20. LLC-PK1 and PAEC were cultured as reported previously (5).
Measurement of Intracellular cAMP Production
The full-length cDNAs of CTR (3.0 kbp), CRLR (1,822 bp), RAMP1 (800 bp), RAMP2 (750 bp) and RAMP3 (533 bp) were ligated into pcDNA3.1 expression vector (Promega, Madison, USA), and were designated pcDNA/CTR, pcDNA/ CRLR, pcDNA/RAMP1, pcDNA/RAMP2, pcDNA/RAMP3, respectively. As a control, an insert-free plasmid prepared by the same reagents and preparation kits was checked and confirmed to be free from cytotoxicity. Each plasmid expression vector carrying an insert was transformed into E. coli (XL1-blue), which was cultured in a volume of 50 ml. The plasmid was prepared from the culture broth with an Endo Free Maxi kit (Qiagen, Valencia, USA). COS-7 cells and PASMC were harvested and cultured on 24-well collagen-coated culture plates (Iwaki Glass, Tokyo, Japan) at a concentration of 7 10 4 cells per well and 4 10 4 cells per well, respectively. COS-7 cells were cultured for 36 h without antibiotics and PASMCs for 3 days with antibiotics before transfection. The plasmid was transfected into COS-7 cells or PASMCs by lipofectamine 2000 (Invitrogen Life Technologies). After washing twice with 0.5 ml of DMEM, 0.5 µg each of two different plasmids was added to each well of the culture plate according to the manufacturer's protocol. When only pcDNA/CRLR or pcDNA/CTR was transfected, 0.5 µg of an insert-free pcDNA3.1 was also added to each well. The transfected cells were analyzed at 24 h after transfection. The cells were washed twice with 0.5 ml of DMEM/Hepes (20 mmol/l, pH 7.4) containing 0.5 mmol/l 3-isobutyl-1-methyl xanthine (IBMX; Sigma, St. Louis, USA) and 0.01% BSA, and were incubated in the same medium for 60 min at 37 ºC. The incubation medium was then replaced with 200 µl of the medium in which the sample of interest was dissolved, and further incubated at 37 ºC for another 60 min. Aliquots of the incubation media were collected, and succinylated with succinic anhydride. The resulting solution was lyophilized, dissolved in the radioimmunoassay (RIA) standard buffer for the cyclic adenosine 3 ,5 -monophosphate (cAMP) assay, and submitted for RIA of cAMP. The RIA was performed as reported previously (21) , and the antiserum against cAMP was donated by K. Kitamura and T. Eto (Miyazaki Medical College, Miyazaki, Japan).
PCR Analysis of Expression Levels of RAMPs
Total RNA was extracted from PASMC, PAEC and LLC-PK1 with RNAzol (Tel-Test, Friendswood, USA). Total RNA (10 µg) was reverse-transcribed using Superscript II as described above. For each PCR reaction, we used 1/50 of the cDNA reaction mixture, 0.2 mmol/l of each dNTP, 40 U/ml of recombinant Taq polymerase (Toyobo), a 1-fold concentration of the reaction buffer provided with the enzyme, and a pair of PCR-specific primers (1 µmol/l of each). The amplification was performed for 30 cycles (each cycle consisted of 20 s at 94 ºC and 60 s at 68 ºC). The PCR products were then separated on 2% TAE-agarose gel. The following gene-specific primers were used: TCACCTCTTC TTGGCCACC and GACGGGGCAGTTTCTGAAGT for RAMP1; TCCCTGGCTCAGCATTTTCC and CGCATCTG CTTTCTGTTCC for RAMP2; CCGGAATTCACAGCTGG CTAGCCATGGA and CCGGAATTCGCCCTTCTCACAC CACCT for RAMP3; CCGGAATTCAGTTCCACGGCAC AGTCAAG and CCACTCGAGGGGATGATGTTCTGGG CAG for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (accession number: AF202970).
Statistical Analysis
Statistical analysis of the results was performed by one-way analysis of variance (ANOVA), followed by a multiple comparison test (Dunnett's test), at the level of the cAMP concentration (fmol/well). All data were expressed as the means SEM. Values of p 0.05 were considered to indicate statistical significance.
Results
Cloning of Porcine CRLR, RAMP1, RAMP2 and RAMP3
We cloned and sequenced the full-length cDNA of the porcine RAMP family. Figure 1 shows the deduced amino acid sequences of porcine RAMP1, RAMP2 and RAMP3, and their nucleotide sequences have been submitted to DDBJ (accession numbers: AB090163, AB090164, AB090165). The porcine RAMP1, RAMP2 and RAMP3 precursor proteins, including the signal peptides, were deduced to be 148, 177 and 151 amino acids in length, and to show 68.2%, 74.6% and 70.9% identity with the respective human proteins, and 69.6%, 65.9% and 77.1% identity with the respec-tive rat proteins (10, 20, 22) . The identity of the porcine RAMP family in the amino acid sequence was 35.4%, which was slightly higher than that of the human (31.4%) or rat (34.4%) RAMP family. All cysteine residues commonly found in human and rat RAMPs were conserved in porcine RAMPs, and the numbers of potential N-glycosylation sites in porcine RAMPs were comparable with those of human RAMPs, with the single exception that porcine RAMP3 lacked one site.
We also cloned porcine full-length CRLR from the porcine lung cDNA library and sequenced it (accession number: AB090162). The nucleotide sequence of porcine CRLR was recently reported, and only one nucleotide is different between the reported sequence and the present sequence; this difference does not translate into a different amino acid (23) . We further cloned and sequenced porcine full-length CTR for transfection and expression, with the resulting sequence corresponding to human CTR2 and rat C1a CTR (24, 25) .
Stimulatory Effects of AM, CGRP, AMY and CT on cAMP Production of COS-7 Cells Transfected with cDNAs of CRLR and RAMPs
We used the COS-7 expression system for transfection of pcDNA/RAMPs, pcDNA/CRLR and pcDNA/CTR, because COS-7 cells are known to express low levels of RAMP genes compared with other cell lines often used for transfection, such as HEK293 cells (10) (11) (12) (13) (14) 26) . With respect to peptide ligands, we were able to use porcine CGRP and CT for the present study. Human peptides were used in the cases of AM and AMY, because the respective porcine peptides were not commercially available. The amino acid sequence of porcine AMY has not been completely determined, and porcine and human AMY have been deduced to have relatively large diversity (accession number: U62628).
In Fig. 2 , the basal cAMP level of each set of the experiment was measured to be (A) 967 53, (B) 899 15, (C) 821 74, and (D) 763 44 fmol/well. In the COS-7 cells expressing CRLR alone, some peptides of the CGRP/CT family weakly stimulated the adenylyl cyclase activity. When pcDNA/RAMP1 was co-transfected with pcDNA/CRLR, CGRP and AM markedly increased the cAMP concentration more than 60-fold, but the potency of CGRP was 100-fold greater than that of AM. On the other hand, CT and AMY did not alter the adenylyl cyclase activity in these COS-7 cells even at the concentration of 10 6 mol/l. When pcDNA/RAMP2 or pcDNA/RAMP3 was co-transfected with pcDNA/CRLR, AM gave the most potent stimulation of the adenylyl cyclase and increased the cAMP concentration from 10 10 mol/l ( Fig. 2C and D) . CGRP also increased the cAMP production, but its half-maximal effective dose (ED50) was 100-to 500-fold greater than that of AM. In the CRLR/RAMP2-or CRLR/RAMP3-expressing system, the maximal cAMP concentration achieved by AM was lower than that in the CRLR/RAMP1-expressing system.
Stimulatory Effects of AM, CGRP, AMY and CT on cAMP Production of COS-7 Cells Transfected with cDNAs of CTR and RAMPs
Although the experimental conditions were not identical, basal cAMP levels of COS-7 cells were highly increased when pcDNA/CTR was transfected. In Fig. 3 , the basal cAMP concentrations for each set of the experiments were determined to be (A) 6,650 360, (B) 16,080 860, (C) 12,430 730, and (D) 6,430 220 fmol/well, each of which was more than 6-fold of the value shown in Fig. 2A .
In contrast with CRLR, all four of these peptides stimulated adenylyl cyclase activity in the COS-7 cells expressing only CTR, and the maximal cAMP production level in Fig.  3A was 3-fold higher than that in Fig. 2A . Among the four peptides, CT most strongly stimulated the adenylyl cyclase. AMY, CGRP and AM increased the cAMP level at about 10%, 10% and 1% potency of CT, respectively. When pcDNA/RAMP2 was co-transfected with pcDNA/CTR, CGRP, AM, CT and AMY elicited effects comparable to those by transfection with pcDNA/CTR alone. In cases in which CTR and RAMP1 were expressed together, the relative potency of CGRP was elevated, and CT and CGRP 
Fig. 1. Amino acid sequences of porcine RAMP1, RAMP2 and RAMP3 aligned for comparison with human and rat RAMPs. The number on the right refers to the last amino acid on the line. Black boxes indicate amino acids conserved in more than two species.
Fig. 2. Stimulation of adenylyl cyclase activity of COS-7 cells expressing CRLR and RAMP1, RAMP2 or RAMP3 with CGRP, AM, AMY and CT. The cells were stimulated with the indicated concentrations of CGRP (open circle), AM (closed circle), CT (open square) or AMY (open triangle). COS-7 cells were transfected with (A) pcDNA/CRLR alone, (B) pcDNA/CRLR plus pcDNA/RAMP1, (C) pcDNA/CRLR plus pcDNA/RAMP2, or (D) pcDNA/CRLR plus pcDNA/RAMP3, cultured for 24 h, and then were used for the experiments. Adenylyl cyclase activity was evaluated by measuring the cAMP concentration in the culture medium with the specific RIA after 60-min stimulation. Each point represents the mean SEM of three separate determinations. All values greater than 3-fold stimulation are significantly higher than the basal cAMP level.
Fig. 3. Stimulation of adenylyl cyclase activity of COS-7 cells expressing CTR and RAMP1, RAMP2 or RAMP3 with CGRP, AM, AMY and CT. The cells were stimulated with the indicated concentrations of CGRP (open circle), AM (closed circle), CT (open square) or AMY (open triangle). COS-7 cells were transfected with (A) pcDNA/CTR alone, (B) pcDNA/CTR plus pcDNA/RAMP1, (C) pcDNA/CTR plus pcDNA/RAMP2, or (D) pcDNA/CTR plus pcDNA/RAMP3
, and the experiments were performed as described in Fig. 2 
. Each point represents the mean SEM of three separate determinations. All values greater than 3-fold stimulation are significantly higher than the basal cAMP level.
showed overlapped dose-response curves. Although the foldincrease achieved by co-transfection of pcDNA/CTR with pcDNA/RAMP1 or pcDNA/RAMP2 was lower than that induced by the transfection of pcDNA/CTR, the maximal cAMP levels elicited in these three systems were similar (Fig. 3A-C) . This difference in the fold-increase was derived from the different basal cAMP levels in each system. When pcDNA/RAMP3 was co-transfected with pcDNA/CTR, the dose-response curves of all peptides were shifted to the right side, and the ED50 value of each peptide was increased more than 20-fold compared with that by transfection with pcDNA/CTR alone. On the other hand, the relative potencies of CT, CGRP, AMY and AM remained unchanged in the CTR/RAMP3 system.
Expression of RAMP Genes in PASMC, PAEC and LLC-PK1
We examined the receptor specificity of the porcine CTR/RAMPs by expressing them in the COS-7 cells, and the results were distinct from those reported previously (13, 14) . Thus, we searched for porcine cultured cells that did not express RAMP genes using the PCR procedures, in order to reexamine the effects of RAMPs on CTR. We checked three different porcine cultured cells. Fortunately, PASMC was found to express none of the RAMP genes by the present detection method, although GAPDH mRNA was clearly observed in a simultaneous experiment (data not shown). RAMP2 gene expression was observed in PAEC, which was consistent with our previous findings (5), and LLC-PK1 was found to express the RAMP1 and RAMP2 genes. Thus, we used PASMC for the following study.
Stimulatory Effects of AM, CGRP, AMY and CT on cAMP Production of PASMC Transfected with cDNAs of CTR and RAMPs
Basal cAMP levels of PASMC were much lower than those of COS-7 cells. In Fig. 4 , the basal cAMP concentrations for each transfection system were measured to be (A) 459 17, (B) 225 16, (C) 554 16, and (D) 211 46 fmol/well, which values were all less than 10% of those for the respective CTR/RAMP systems expressed in the COS-7 cells.
A marked difference between COS-7 cells and PASMC was observed when pcDNA/CTR was transfected (Fig. 4) . The dose-response curves of all peptides were shifted to the right side, and the ED50 value of each peptide was increased more than 20-fold. Expression of RAMP1 with CTR did not shift the dose-response curves of CT, CGRP, AMY and AM compared with those in the CTR-expressing system. When Fig. 2 
Fig. 4. Stimulation of adenylyl cyclase activity of PASMCs expressing CTR and RAMP1, RAMP2 or RAMP3 with CGRP, AM, AMY and CT. The cells were stimulated with the indicated concentrations of CGRP (open circle), AM (closed circle), CT (open square) or AMY (open triangle). PASMCs were transfected with (A) pcDNA/CTR alone, (B) pcDNA/CTR plus pcDNA/RAMP1, (C) pcDNA/CTR plus pcDNA/RAMP2, or (D) pcDNA/CTR plus pcDNA/RAMP3, and the experiments were performed as described in
. Each point represents the mean SEM of three separate determinations. All values greater than 3-fold stimulation and those at 10
6 mol/l in addition to CGRP and AMY at 10 7 mol/l in (A) are significantly higher than the basal cAMP level.
pcDNA/RAMP2 or pcDNA/RAMP3 was co-transfected with pcDNA/CTR into PASMCs, no apparent changes in the cAMP production were observed.
Discussion
The amino acid sequences determined for precursors of porcine RAMP1, RAMP2 and RAMP3 are relatively conserved compared with those of the respective human and rat RAMP precursors (65.9-77.1% conservation; Fig. 1 ). High identity was observed in the C-terminal half of each precursor including the transmembrane domain. On the other hand, the amino acid sequences of porcine, human and rat CRLR precursors are more highly conserved (89.2-92.9%) than those of RAMPs (11, 23, 27) . These findings suggest that mammalian RAMPs are well conserved but have more diversity than CRLRs in the amino acid sequence, which may suggest the possibility that RAMPs have slightly different properties in each species.
As shown in Fig. 2A , CGRP and AM only weakly stimulated the adenylyl cyclase in the COS-7 cells transfected with pcDNA/CRLR alone. This result confirmed the low expression levels of RAMPs in COS-7 cells. Co-transfection of pcDNA/CRLR with pcDNA/RAMP1 resulted in expression of a functional CGRP receptor having an ED50 value of about 10 10 mol/l (Fig. 2B) . AM also stimulated the CRLR/RAMP1 system, but its potency was less than 1% that of CGRP. On the other hand, expression of RAMP2 or RAMP3 with CRLR constituted a functional AM receptor, although a slight difference in the affinity of AM and CGRP may be present between RAMP2 and RAMP3 expression systems. CT and AMY did not clearly stimulate the cAMP production in the COS-7 cells expressing the porcine CRLR/RAMP system. These findings were consistent with those reported previously for the human CRLR/RAMP system, and it was confirmed that RAMPs define the ligand specificity of CRLR (10, 26) .
In contrast, the expression of CTR alone in COS-7 cells generated a CT-specific receptor (Fig. 3A) . CT stimulated the adenylyl cyclase with an ED50 value of about 10 8 mol/l, which was compatible with previous findings (24) . AMY, CGRP and AM also increased the cAMP production, and these peptides retained about 10%, 10%, and 1% potency for the CTR. Co-expression of RAMP1 or RAMP2 did not alter the affinity of CT, AMY or AM to CTR. Only CGRP significantly increased its affinity for CTR to a level comparable to that of CT when RAMP1 was co-expressed (Fig. 3B ). RAMP2 and RAMP3 were recently reported to directly participate in the formation of the ligand-recognition structure of the CRLR/RAMP system (28) . These findings suggest that RAMP1 is also involved in the ligand recognition of the CRLR and CTR systems. On the other hand, the expression of RAMP3 decreased the affinity of all four of these peptides for the CTR. Co-expression of human RAMP1 or RAMP3 with CTR was reported to increase the affinity of AMY for CTR in the CTR/RAMP system (13, 14) , but we failed to observe any positive change in the porcine system. With respect to the effect of RAMP3, a partial reduction of the affinity of CT for CTR was reported in the human CTR/RAMP system (14) .
We next examined the porcine CTR/RAMP system under the homogenous experimental conditions using PASMC. As shown in Fig. 4 , CT was also the most potent stimulant in the cAMP production when porcine CTR was expressed in PASMC. Co-expression of RAMPs in the PASMC system did not alter the stimulatory effects of the CGRP/CT superfamily on the adenylyl cyclase. These findings at least suggest that an AMY-specific receptor complex is not formed by expressing the porcine CTR/RAMP system in the PASMC. The finding that the potencies and reactivities of CT, AMY, CGRP and AM in the PASMC system were lower than those in the COS-7 system was likely due to the differences in the intrinsic system of each cultured cell, such as differences in transfection and expression efficiency, glycosylation and sorting of proteins, and subtypes of coupling G proteins and adenylyl cyclases.
Both CTR and CRLR are GPCRs belonging to the secretin receptor subclass, and their amino acid sequences are approximately 59% homologous. Through identification of RAMPs in 1998, McLatchie et al. (10) demonstrated the complexity of the GPCR system, especially in regard to its translocation and ligand specificity, which also provides more elaborate regulation to the CGRP/CT superfamily. In the present study, we confirmed that RAMPs can generally determine the specificity of core receptor CRLR, and that AM-and CGRP-specific receptors are formed by the CRLR/RAMP system. In the case of the porcine CTR/RAMP system, however, we found a very limited effect of RAMPs on the CTR specificity.
In the case of CTR, RAMPs are not essential for translocating CTR to the cell membrane in contrast with CRLR (10, 14) . Two types of receptors may be expressed together on the cell surface; one is CTR and the other is a complex of CTR/RAMP. Since all peptides of the CGRP/CT superfamily can activate the adenylyl cyclase through CTR, the effects of the CTR/RAMP complex could be reduced or masked by those of CTR. For differentiating and characterizing the two types of receptors, the receptor binding assay using different 125 I-labeled ligands is expected to provide more information. It is also important to identify the cell line which endogenously expresses each set of the CTR/RAMP system and to characterize the receptors on the cell surface, because the transfection system does not always form an expected receptor complex in the CTR/RAMP system.
As major physiological effects of AMY, inhibition of osteoclast-mediated bone resorption and suppression of appetite have been reported (29, 30) . CT is known to regulate the feeding behavior in addition to the calcium metabolism, and its receptor is abundantly expressed in the central nervous system (31, 32) . These physiological findings also sup-port the possible interaction of AMY with the CTR system. To provide a molecular basis for AMY as a peptidergic regulator, it is necessary to analyze the porcine CTR/RAMP system under completely homogenous and characterized conditions.
As shown in this study, CTR itself has a rather broad specificity for the CGRP/CT superfamily, and its affinity for CT is not particularly high. Furthermore, known RAMPs do not increase the affinity of CT for CTR (Fig. 3) . In contrast, the CRLR/RAMP system creates the highly specific ligandreceptor system for CGRP and AM by differentially expressing RAMPs (Fig. 2) . These findings may suggest the presence of other RAMPs or cognate ligands for the CTR.
In conclusion, the CRLR/RAMP system is valid in the porcine system, and functional AM and CGRP receptors are formed by co-expression of CRLR and RAMPs. In contrast to the findings of previous studies, porcine RAMPs were unable to form AMY receptor by co-expression with CTR based on the present assay of cAMP production.
